Madrigal Pharmaceuticals ... (MDGL)
270.03
-4.09 (-1.49%)
At close: Jan 15, 2025, 12:36 PM
Price Reaction to Earnings Reports
This table provides an overview of how a stock's price historically reacted around earnings reports. It displays key metrics like price changes over specific timeframes and Relative Strength Index (RSI).
| Report Date | -3 Days | -2 Days | -1 Day | Open | High | Low | Close | +1 Day | +2 Days | +3 Days | +1 Week | -1 Week | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct 31, 2024
(Q3) BMC Q3 2024 | 217.79 | 215.93 | 259.34 | 274.98 | 321.19 | 262.85 | 319.58 | 331.32 | 337.61 | 338.22 | 350.70 | 210.67 | ||
IV: 0.68 RSI: 74 MDGL % | 0.36% | -0.85% | -0.85% | 6.03%
| 23.85%
| 1.35%
| 23.23%
| 3.67% | 1.90% | 0.18% | -1.17% | 3.78% | ||
Aug 7, 2024
(Q2) BMC Q2 2024 | 259.45 | 266.56 | 234.08 | 241.18 | 244.05 | 231.67 | 243.64 | 237.00 | 242.09 | 243.64 | 244.50 | 278.48 | ||
IV: 0.55 RSI: 31 MDGL % | -5.78% | 2.74% | 2.74% | 3.03%
| 4.26%
| -1.03%
| 4.08%
| -2.73% | 2.15% | 0.64% | 0.50% | -2.17% | ||
| Daily change and RSI 14 are based on the report date for BMO releases and the following day for AMC releases. | ||||||||||||||
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options Data
- Instant access to live options data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.